Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers

[1]  N. Inagaki,et al.  Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice. , 1998, Life sciences.

[2]  K. Masuyama,et al.  Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate. , 1996, Immunopharmacology and immunotoxicology.

[3]  S. Xu,et al.  Human conjunctival epithelial cells express histamine-1 receptors coupled to phosphoinositide turnover and intracellular calcium mobilization: role in ocular allergic and inflammatory diseases. , 1996, Experimental eye research.

[4]  N. Sharif,et al.  Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies. , 1994, Journal of ocular pharmacology.

[5]  J. Yanni,et al.  Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use. , 1994, Journal of ocular pharmacology.

[6]  T. Saito,et al.  Inhibitory effects of emedastine difumarate on histamine release. , 1993, Japanese journal of pharmacology.

[7]  K. Yokota,et al.  General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems. , 1988, Arzneimittel-Forschung.

[8]  T. Saito,et al.  General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system. , 1988, Arzneimittel-Forschung.

[9]  T. Saito,et al.  [Anti-allergic effects of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole fumarate (KB-2413)]. , 1987, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[10]  K Ito,et al.  Inhibition of chemical mediator release from human leukocytes and lung in vitro by a novel antiallergic agent, KB-2413. , 1987, Immunopharmacology and immunotoxicology.

[11]  C. Kamei,et al.  Comparative study of various H1-blockers on neuropharmacological and behavioral effects including 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate (KB-2413), a new antiallergic agent. , 1986, Archives internationales de pharmacodynamie et de therapie.

[12]  Å. Lanner,et al.  Reproducibility of Histamine Skin Prick Test , 1985 .